Here are what the editors at HealthDay consider to be the most important developments in Urology for June 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Trump Administration Asks Supreme Court to Overturn Affordable Care Act
FRIDAY, June 26, 2020 (HealthDay News) — The Trump administration has asked the Supreme Court to overturn the Affordable Care Act (ACA).
African-American Participation Inadequate in Cancer Drug Trials
TUESDAY, June 23, 2020 (HealthDay News) — African-Americans are underrepresented in clinical trials leading to approval of cancer medications, according to a research letter published online June 23 in the Annals of Internal Medicine.
Safety Climate Perceptions Linked to Health Provider Stress
MONDAY, June 22, 2020 (HealthDay News) — Safety climate perceptions are associated with care practitioner-reported stress and job satisfaction, according to a study published in the May-June issue of the Journal of Healthcare Management.
Court Rules Against Drug Price Disclosures in TV Ads
THURSDAY, June 18, 2020 (HealthDay News) — The U.S. government does not have the legal authority to force drug companies to disclose prices in their TV ads, a federal appeals court says.
Risk Factors for Suicide ID’d in Health Care Professionals
THURSDAY, June 11, 2020 (HealthDay News) — Modifiable and nonmodifiable risk factors for suicide have been identified among health care professionals, according to a study published online June 10 in JAMA Surgery.
Prostate Cancer Trial Participants Overwhelmingly White
TUESDAY, June 9, 2020 (HealthDay News) — Prostate cancer clinical trial participants are overwhelmingly white, according to a study published online June 5 in Cancer Epidemiology, Biomarkers & Prevention.
Diet, Activity Guideline Updated by American Cancer Society
TUESDAY, June 9, 2020 (HealthDay News) — The diet and physical activity guideline for the prevention of cancer has been updated by the American Cancer Society; the guideline was published online June 9 in CA: A Cancer Journal for Clinicians.
Postoperative Lung Complications Common in Patients With SARS-CoV-2
FRIDAY, June 5, 2020 (HealthDay News) — About half of patients with perioperative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have postoperative pulmonary complications, which are associated with high 30-day mortality, according to a study published online May 29 in The Lancet.
Copyright © 2020 ScoutNews, LLC. All rights reserved.